<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Toxic Dolls | Vaughan Lang | Activity</title>
	<link>http://toxicdolls.com/members/nationreason4/activity/</link>
	<atom:link href="http://toxicdolls.com/members/nationreason4/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Vaughan Lang.</description>
	<lastBuildDate>Sun, 15 Nov 2026 14:17:13 +0000</lastBuildDate>
	<generator>https://buddypress.org/?v=</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">1a9931687e79b3984a8479003f94bbc8</guid>
				<title>Vaughan Lang posted an update: Recently, the international market for study peptides has [&#133;]</title>
				<link>http://toxicdolls.com/activity-2/p/113912/</link>
				<pubDate>Tue, 21 Oct 2025 18:42:49 +0000</pubDate>

									<content:encoded><![CDATA[<p>Recently, the international market for study peptides has garnered considerable attention from scientists, biotech firms, and fitness enthusiasts alike. These short chains of protein fragments play a critical role in numerous biological processes and have been the subject of many studies aimed at revealing their possible benefits in medical&hellip;<span class="activity-read-more" id="activity-read-more-113912"><a href="http://toxicdolls.com/activity-2/p/113912/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">6c2a09827e1468828907b6a668eb655a</guid>
				<title>Vaughan Lang became a registered member</title>
				<link>http://toxicdolls.com/activity-2/p/113894/</link>
				<pubDate>Mon, 20 Oct 2025 17:59:36 +0000</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>